These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16368949)

  • 1. Re: Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Paci E; Ponti A; Crocetti E; Zappa M; Segnan N
    J Natl Cancer Inst; 2005 Dec; 97(24):1853-4; author reply 1854. PubMed ID: 16368949
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cancer registry and clinical data as predictors for breast cancer survival.
    Seppänen J; Heinävaara S; Holli K; Hakulinen T
    Cancer Causes Control; 2008 Dec; 19(10):1299-304. PubMed ID: 18752035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The University of Rochester model of breast cancer detection and survival.
    Hanin LG; Miller A; Zorin AV; Yakovlev AY
    J Natl Cancer Inst Monogr; 2006; (36):66-78. PubMed ID: 17032896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401.
    ; Tanner M; Isola J; Wiklund T; Erikstein B; Kellokumpu-Lehtinen P; Malmström P; Wilking N; Nilsson J; Bergh J
    J Clin Oncol; 2006 Jun; 24(16):2428-36. PubMed ID: 16682728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
    Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
    Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening in women at elevated risk for breast cancer.
    Schmutzler RK; Engel C; Schreer I
    J Clin Oncol; 2010 Oct; 28(30):e607-8; author reply e609-10. PubMed ID: 20855835
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
    Zackrisson S; Janzon L; Manjer J; Andersson I
    J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Get the facts straight.
    Kopans DB
    J Clin Oncol; 2004 Dec; 22(23):4859; author reply 4860-2. PubMed ID: 15570093
    [No Abstract]   [Full Text] [Related]  

  • 10. Some issues in screening for breast and other cancers.
    Duffy SW; McCann J; Godward S; Gabe R; Warwick J
    J Med Screen; 2006; 13 Suppl 1():S28-34. PubMed ID: 17227639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teaching breast self-examination in developing countries does not reduce breast cancer deaths.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Nov; 13(21):5-7. PubMed ID: 12625314
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast cancer. The influence of early diagnosis on survival.
    Anglem TJ; Leber RE
    Geriatrics; 1972 Jul; 27(7):85-91. PubMed ID: 5039886
    [No Abstract]   [Full Text] [Related]  

  • 13. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
    Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
    Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
    Cheang MC; Treaba DO; Speers CH; Olivotto IA; Bajdik CD; Chia SK; Goldstein LC; Gelmon KA; Huntsman D; Gilks CB; Nielsen TO; Gown AM
    J Clin Oncol; 2006 Dec; 24(36):5637-44. PubMed ID: 17116944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should screen-detected breast cancers be managed differently?
    Krzyzanowska MK; Tannock IF
    J Natl Cancer Inst; 2005 Aug; 97(16):1170-1. PubMed ID: 16106016
    [No Abstract]   [Full Text] [Related]  

  • 17. Multifocal breast cancer in women < or =35 years old.
    Litton JK; Eralp Y; Gonzalez-Angulo AM; Broglio K; Uyei A; Hortobagyi GN; Arun B
    Cancer; 2007 Oct; 110(7):1445-50. PubMed ID: 17676585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to T classification in tumor-node-metastasis staging of breast cancer.
    Coburn NG; Clarke-Pearson E; Chung MA; Law C; Fulton J; Cady B
    Am J Surg; 2006 Oct; 192(4):434-8. PubMed ID: 16978944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival rates for breast cancers detected in a community service screening mammogram program.
    Sener SF; Winchester DJ; Winchester DP; Barrera E; Bilimoria M; Brinkmann E; Alwawi E; Rabbitt S; Schermerhorn M; Du H
    Am J Surg; 2006 Mar; 191(3):406-9. PubMed ID: 16490556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonparametric estimation of asymptomatic duration from a randomized prospective cancer screening trial.
    Shen Y; Huang X
    Biometrics; 2005 Dec; 61(4):992-9. PubMed ID: 16401272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.